Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization
暂无分享，去创建一个
A. Barabasi | S. Elledge | M. Zitnik | J. Loscalzo | R. Davey | G. Menichetti | S. H. Stubbs | F. Wagner | S. Gummuluru | J. J. Patten | M. Anantpadma | M. Namchuk | S. Jalloh | P. Keiser | Ì. D. Valle | Hiroyuki Mori | S. Ayehunie | X. Gan | Colin O’Leary | D. Anderson | K. Geoghegan-Barek | J. Berrigan | Deisy Morselli-Gysi | C. Donahue | Ruthmabel Boytz | T. Ayazika | RuthMabel Boytz | A. Barabási | Xiao Gan | Callie J. Donahue | Ì. Valle | Manu Anantpadma | Sallieu Jalloh